Neulastim Injection

Neulastim® DS 1402051 Data Sheet Neulastim® Pegfilgrastim 6 mg in 0.6 mL (pre-filled syringe), solution for injection Description Therapeutic/Pharmacologic Class of Medicine Haematopoietic growth factor Pharmacotherapeutic group: Cytokines, ATC Code: L03AA13 Type of Dosage Form Solution for injection in a pre-filled syringe. Route of Administration Subcutaneous injection. Sterile/Radioactive Statement Sterile. Qualitative and Quantitative Composition 6 mg of pegfilgrastim in 0.6 mL (10 mg/mL*) solution for injection. * Based on protein only. The concentration is 20 mg/mL if the PEG moiety is included. Pegfilgrastim is composed of filgrastim (recombinant methionyl human G-CSF) with a 20 kDa polyethylene glycol (PEG) molecule covalently bound to the N-terminal methionine residue. Filgrastim is produced by recombinant DNA technology in E coli (K12). Excipients: Sodium acetate**, Sorbitol, Polysorbate 20, Water for injections ** Sodium acetate is formed by titrating glacial acetic acid with sodium hydroxide